Page last updated: 2024-11-04

rolipram and Pneumonia, Pneumococcal

rolipram has been researched along with Pneumonia, Pneumococcal in 1 studies

Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.

Research Excerpts

ExcerptRelevanceReference
"Pneumococcal pneumonia is a leading cause of mortality worldwide."1.43Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice. ( David, BA; Galvão, I; Garcia, CC; Queiroz-Junior, CM; Rachid, MA; Russo, RC; Silva, PM; Sousa, LP; Tavares, LP; Teixeira, MM; Vago, JP, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tavares, LP1
Garcia, CC1
Vago, JP1
Queiroz-Junior, CM1
Galvão, I1
David, BA1
Rachid, MA1
Silva, PM1
Russo, RC1
Teixeira, MM1
Sousa, LP1

Other Studies

1 other study available for rolipram and Pneumonia, Pneumococcal

ArticleYear
Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
    American journal of respiratory cell and molecular biology, 2016, Volume: 55, Issue:1

    Topics: Animals; Annexin A1; Anti-Bacterial Agents; Ceftriaxone; Cyclic Nucleotide Phosphodiesterases, Type

2016